FM
ABEO icon

Family Management’s Abeona Therapeutics ABEO Stock Holding History

Family Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,440
Closed -$614K – 60
2017
Q3 		$614K Buy
1,440
+480
+50% +$129K 0.42% 35
2017
Q2 		$154K Hold
960
– – 0.11% 61
2017
Q1 		$120K Buy
+960
New +$124K 0.08% 60

Other funds holding ABEO

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return

Family Management's ABEO Position: Q4 2017 in Review

Family Management sold out of Abeona Therapeutics (ABEO) in Q4 2017, closing a stake of 1,440 shares — an estimated $614K sold.

Family Management first reported a position in ABEO in Q1 2017 and held it in 3 quarters. The position peaked at $614K in Q3 2017. 93 funds tracked by Wall St. Rank hold ABEO as of Q4 2017.

  • Family Management reported no remaining Abeona Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Family Management sold 1,440 Abeona Therapeutics shares in Q4 2017, an estimated $614K.
  • Family Management first reported a position in Abeona Therapeutics in Q1 2017 and held it in 3 quarters.
  • Family Management's Abeona Therapeutics position peaked at $614K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2017.

Based on Family Management's 13F filing for Q4 2017, filed 15 Feb 2018.